Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Blood

• Publication date

  1988-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V72.1.294.BLOODJOURNAL721294PMID 3164637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival.

  1985cited by this paper
• Chromosomal characteristics of chronic and blastic phases of Ph-positive chronic myeloid leukemia.

  1985cited by this paper
• Value of cytogenetic studies in prediction of acute phase CML.

  1985cited by this paper
• Prognostic discrimination in "good-risk" chronic granulocytic leukemia.

  1984cited by this paper
• Chromosomes and causation of human cancer and leukemia: XL. The Ph1 and other translocations in CML

  1980cited by this paper
• The cytogenetics of chronic granulocytic leukaemia.

  1977cited by this paper
• Chromosomes and causation of human cancer and leukemia: XXVIII. Value of detailed chromosome studies on large numbers of cells in CML

  1977cited by this paper
• The cytogenetics of chronic granulocytic leukaemia.

  1977cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Identifying Key Factors Influencing Non-adherence to Imatinib Therapy in Patients With Chronic Myeloid Leukemia

  2025cites this paper
• Long-term outcomes of chronic myeloid leukemia in children and adolescents - Real world data from a single-institute in Taiwan.

  2025cites this paper
• Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights

  2023cites this paper
• Control of Ph+ and additional chromosomal abnormalities in chronic myeloid leukemia by tyrosine kinase inhibitors

  2023cites this paper
• Chronic myeloid leukemia in children: a rare and unique entity

  2022cites this paper
• Complex karyotype with double Philadelphia chromosome and T315I mutation results in blastic phase and extensive extramedullary infiltration in a chronic myeloid leukemia patient.

  2022cites this paper
• Myelodysplastic syndromes and myeloproliferative disorders

  2022cites this paper
• Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in The Netherlands

  2022cites this paper
• A Review and an Update of European LeukemiaNet Recommendations for the Management of Chronic Myeloid Leukemia

  2021cites this paper
• Additional chromosomal abnormalities at chronic myeloid leukemia diagnosis predict an increased risk of progression.

  2021cites this paper
• Tyrosine Kinase Inhibitors and Beyond for Chronic Myeloid Leukemia in Children

  2021cites this paper
• Chronic Myeloid Leukemia in Children: Challenges and Opportunities

  2020cites this paper
• ACA Rearrangement is Associated with the Prognosis of CML in the Era of TKI

  2019cites this paper
• How I treat chronic myeloid leukemia in children and adolescents.

  2019cites this paper
• Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update

  2019cites this paper
• Emerging alternatives to tyrosine kinase inhibitors for treating chronic myeloid leukemia

  2018cites this paper
• Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors

  2018cites this paper
• 细胞遗传学检测在慢性髓性白血病中的临床意义

  2017cites this paper
• [Clinical significance of cytogenetic monitoring in chronic myeloid leukemia].

  2017cites this paper
• Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemia

  2017cites this paper
• An unusual translocation, t(1;11)(q21;q23), in a case of chronic myeloid leukemia with a cryptic Philadelphia chromosome.

  2017cites this paper
• Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents

  2017cites this paper
• DNA Methyltransferase 1 Drives Transcriptional Down‐Modulation of β Catenin Antagonist Chibby1 Associated With the BCR‐ABL1 Gene of Chronic Myeloid Leukemia

  2015cites this paper
• Chronic myeloid leukemia

  2015cites this paper
• Hyperdiploidy associated with T315I mutation in BCR-ABL kinase domain in an accelerated phase-chronic myeloid leukemia case

  2014cites this paper
• The Effect of ImatinibMesylate for Newly Diagnosed Philadelphia Chromosome-Positive , Chronic-Phase Myeloid Leukemia in Sub-Saharan African Patients : The Experience of Côte d ’ Ivoire

  2014cites this paper
• Chapter-10 Chronic Myelogenous Leukemia

  2014cites this paper
• Leukemias, Lymphomas, and Other Related Disorders

  2013cites this paper
• CARATTERIZZAZIONE CITOGENETICO-MOLECOLARE ALLA DIAGNOSI DI PAZIENTI CON LEUCEMIA MIELOIDE CRONICA IN FASE CRONICA TRATTATI CON INIBITORI DELLE TIROSINCHINASI: RUOLO PROGNOSTICO

  2013cites this paper
• Prognostic importance of additional cytogenetic anomalies in chronic myeloid leukemia

  2013cites this paper
• Working Party on CML analysis adverse prognostic influence on frontline imatinib therapy: a GIMEMA Additional chromosomal abnormalities in Philadelphia-positive clone:

  2013cites this paper
• Profil cytogénétique des leucémies myéloïdes aigues et chroniques

  2013cites this paper
• CML Study IV of CML: long-term observation of 1151 patients from the randomized Impact of additional cytogenetic aberrations at diagnosis on prognosis

  2012cites this paper
• Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis.

  2012cites this paper
• First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia

  2012cites this paper
• Chronic Myelogenous Leukemia

  2012cites this paper
• A Review of its Pharmacology and Therapeutic Use in the Treatment of Chronic Myelogenous Leukaemia

  2012cites this paper
• Pathophysiology of Chronic Myeloid Leukemia

  2011cites this paper
• Chronic myelogenous leukaemia (CML)

  2011cites this paper
• Selection of therapy: rational decisions based on molecular events.

  2011cites this paper
• 22 ) ( q 34 ; q 11 ) in CML

  2011cites this paper
• Chronic myeloid leukemia: current perspectives.

  2011cites this paper
• t(9;22)(q34;q11) in CML

  2011cites this paper
• Current treatment concepts of CML.

  2011cites this paper
• Chronic myelogenous leukemia in the age of imatinib: assessing response, acceleration, and blast phase

  2011cites this paper
• Therapy of Advanced‐Stage and Resistant Chronic Myeloid Leukemia

  2011cites this paper
• Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.

  2011influential citation
• Prognostic significance of treatment response in CML in view of current recommendations for treatment and monitoring

  2011cites this paper
• BCR/ABL1 Extra Fusions in Patients with Chronic Myeloid Leukaemia (CML)

  2011cites this paper
• Imatinib achieved complete cytogenetic response in a CML patient received 32-year indirubin and its derivative treatment.

  2010cites this paper
• Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation.

  2010cites this paper
• The Effect of Imatinib Mesylate for Newly Diagnosed Philadelphia Chromosome-Positive, Chronic-Phase Myeloid Leukemia in Sub-Saharan African Patients: The Experience of Côte d'Ivoire

  2010cites this paper
• t(9;22)(q34;q11) in ANLL

  2010cites this paper
• Chronic myelogenous leukaemia (CML)

  2010cites this paper
• Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications.

  2010cites this paper
• Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy

  2010cites this paper
• Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results

  2009cites this paper
• Tailoring tyrosine kinase inhibitor therapy in chronic myeloid leukemia.

  2009cites this paper
• Prognostic factors in chronic myeloid leukaemia.

  2009cites this paper
• Myeloid Leukemia, Myelodysplasia, and Myeloproliferative Disease in Children

  2009cites this paper
• European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor.

  2008cites this paper
• Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?

  2008cites this paper
• Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36).

  2008cites this paper
• Current and emerging tests for the laboratory monitoring of chronic myeloid leukaemia and related disorders.

  2008cites this paper
• Philadelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: Clinical correlates and effect on imatinib mesylate treatment outcome

  2007cites this paper
• Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia.

  2007cites this paper
• Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasia

  2006cites this paper
• Jumping translocation of 17q11 approximately qter and 3q25 approximately q28 duplication in a variant Philadelphia t(9;14;22)(q34;q32;q11) in a childhood chronic myelogenous leukemia.

  2006cites this paper
• Jumping translocation of 17q11∼qter and 3q25∼q28 duplication in a variant Philadelphia t(9;14;22)(q34;q32;q11) in a childhood chronic myelogenous leukemia

  2006cites this paper
• Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia

  2006cites this paper
• Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure.

  2006cites this paper
• Prognostic implications of bone marrow features in chronic myelogenous leukaemia

  2005influential citation
• Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment.

  2005cites this paper
• Clonal evolution in chronic myelogenous leukemia.

  2004cites this paper
• Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.

  2004cites this paper
• Recommandations pour la prise en charge cytogénétique d'une leucémie lymphoïde chronique établies par le Groupe Français de Cytogénétique Hématologique (GFCH)

  2004cites this paper
• [Recommendations for the cytogenetic management of chronic myeloid leukemia (CML) proposed by the French Group for Cytogenetic Hematology].

  2004cites this paper
• Natural history and staging of chronic myelogenous leukemia.

  2004cites this paper
• Accelerated and blastic phases of chronic myelogenous leukemia.

  2004cites this paper
• Chronic myelogenous leukemia: A review and update of therapeutic strategies

  2003cites this paper
• Chromosomal abnormalities in Philadelphia chromosome‐negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome‐positive chronic myelogenous leukemia in chronic phase

  2003cites this paper
• Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases.

  2003cites this paper
• Advanced-phase chronic myeloid leukemia.

  2003cites this paper
• Chronic Myelogenous Leukemia : A Concise Update

  2003cites this paper
• Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies

  2003cites this paper
• Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate

  2003cites this paper
• Trisomy X in Philadelphia chromosome-negative cells during the course of Philadelphia chromosome-positive chronic myelocytic leukemia.

  2003cites this paper
• Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy.

  2003cites this paper
• Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid Leukemia

  2002cites this paper
• Cytogenetics of chronic myeloid leukaemia.

  2001cites this paper
• Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia

  2001cites this paper
• Chronic myelogenous leukemia as gene activation model in oncology minireview.

  2000cites this paper
• Amplification of BCR-ABL rearrangement in atypical Philadelphia chromosome: a new variant detected by fluorescence in situ hybridization in one case of acute lymphoblastic leukemia.

  1999cites this paper
• Trisomy 21 is a recurrent secondary aberration in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion

  1999cites this paper
• A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study Group.

  1998cites this paper
• A long term follow-up of a randomized trial comparing interferon-α with busulfan for chronic myelogenous leukemia

  1998cites this paper
• Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

  1998cites this paper
• p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukaemia.

  1997cites this paper
• Hypereosinophilic syndrome or chronic eosinophilic leukemia: report of a case with a lytic bone lesion

  1997cites this paper
• Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.

  1997cites this paper